Christopher Gaglio

clinical trial associate at Cortexyme - South San Francisco, CA, US

Christopher Gaglio's Colleagues at Cortexyme
Rochelle Barlis

Sr. Clinical Research Associate

Contact Rochelle Barlis

David Hennings

Vice President, Chemistry, Manufacturing and Controls

Contact David Hennings

Madison Benesh

Lead Clinical Research Associate

Contact Madison Benesh

View All Christopher Gaglio's Colleagues
Christopher Gaglio's Contact Details
HQ
800-952-5210
Location
Company
Cortexyme
Christopher Gaglio's Company Details
Cortexyme logo, Cortexyme contact details

Cortexyme

South San Francisco, CA, US • 50 - 99 Employees
BioTech/Drugs

Cortexyme is a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimer's and other degenerative diseases. Cortexyme is targeting a specific pathogen found in the brain of Alzheimer's patients that causes neurodegeneration and other pathology in animal models. Cortexyme's lead small molecule, atuzaginstat (COR388), has advanced through Phase Ib and is currently the subject of a Phase 2/3 GAIN clinical trial in mild to moderate Alzheimer's disease patients.

Alzheimer's neuroscience neurodegenerative disease Alzheimer's B2B BioTech/Drugs Commercial Physical Research Biotechnology
Details about Cortexyme
Frequently Asked Questions about Christopher Gaglio
Christopher Gaglio currently works for Cortexyme, Inc.
Christopher Gaglio's role at Cortexyme, Inc is clinical trial associate.
Christopher Gaglio's email address is ***@cortexyme.com. To view Christopher Gaglio's full email address, please signup to ConnectPlex.
Christopher Gaglio works in the Biotechnology industry.
Christopher Gaglio's colleagues at Cortexyme are Dina Cooper, Kirk Ehmsen, Rochelle Barlis, Aurora Martinez-Horta, Stewart Low, David Hennings, Madison Benesh and others.
Christopher Gaglio's phone number is ["+12032520648"]
See more information about Christopher Gaglio